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Background: To compare H. pylori serology 
testing with histopathological biopsy, in patients 
with perforated peptic ulcer. 
Methods: This cross sectional study was performed 
 to document the diagnostic accuracy of H. pylori 
serology in patients with perforated duodenal ulcer. 
Perforated peptic ulcer was diagnosed on the basis 
of history, clinical findings and presence of free gas 
under the diaphragm on an x-ray. All individuals 
fulfilling inclusion criteria underwent laparotomy. 
Blood samples were sent for H Pylori serology by 
enzyme linked immunosorbent assay. At the same 
time, gastric antral biopsies were taken for 
histopathology for H. pylori.  
Results: Sstudy included 191 patients with 
diagnosed perforated peptic ulcer at laparotomy. 
Majority (70.2%) were males. The mean age was 
41.72 years. In majority the perforation was seen 
along the first part of duodenum (76.4%). H. pylori 
serology was positive in 69.1% patients. One 
hundred and thirty nine (72.8%) patients had 
positive histopathology for H pylori. Out of these, 
92.8% also had a positive H. pylori serology. Fifty 
two (27.2%) patients had negative histopathology for 
H. pylori. Out of these 5.8% had a positive serology 
test. One hundred and twenty nine were true 
positive i-e both had positive histopathology and 
serology and 52 were true negative i.e., they had both 
a negative serology and a negative histopathology. 
The results were therefore correct in 94.76%. The 
overall accuracy of serology in comparison to 
histopathology was 94.76%. The calculated 
sensitivity, specificity, positive predictive value and 
negative predictive value of serology in comparison 
to histopathology was 92.8%, 94.5%, 97.7% and 83.9% 
respectively.   
Conclusion: A high prevalence of H. pylori 
infection was found in patients with perforated 
peptic ulcers. Overall accuracy of serology in 
comparison to histopathology was 94.76%. 
Serological testing is a useful noninvasive method 
for the diagnosis of Helicobacter pylori infection. 




      Erosive injury of the gastro duodenal mucosa 
leading to peptic ulcer occurs secondary to destruction 
of the protective layers of the gastric mucosa by a 
variety of etiologies.1 The most important factor is 
Helicobacter pylori, commonly presenting as a chronic 
infection found worldwide in patients of perforated 
peptic ulcer.2 Other causes include prolonged use of 
non-steroidal anti-inflammatory drugs, 
immunosuppressive medications, smoking, alcohol 
abuse and psychological stress.3 In the East, infection 
with H.pylori occurs at a younger age while in the 
West, peak incidence is more in the adult age groups. 
Reported incidence varies from 90% of cases of 
duodenal ulcer (DU) and over 70% of gastric ulcers.4    
   Among its several complications, including chronic 
gastritis, atrophic gastritis, MALT lymphoma, the 
commonest complication in the surgical emergency is 
perforation of a peptic ulcer.6 After resuscitation and 
initial investigations, the patient is prepared for 
emergency laparotomy. Once the diagnosis is 
confirmed, an omental patch repair (Graham’s patch) 
followed by H.pylori eradication therapy is 
suggested.7, 8 
      Considering the significant mortality and 
morbidity associated with perforated peptic ulcer 
disease  and the obvious role of H Pylori infestation in 
its pathogenesis, investigations to detect H.pylori are 
gaining obvious and due attention.9 These can be 
either invasive or endoscopic, including the rapid 
urease test, histology, smear cytology and culture; or 
non-invasive tests, like C14 or C13 urea breath test and 
serology.10-13  
    ‘Test and treat’ strategy that involves non-invasive 
testing without endoscopy and eradication therapy in 
patients is effective in management of peptic ulcers. 
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This calls for a simple, reliable and non-invasive 
diagnostic test for  H.pylori  infection in clinical 
practice. At present histopathology and biopsy 
however requires endoscopic biopsy of gastric 
mucosal tissue that is expensive, inconvenient for the 
patient and available only at specialized centers. 
Moreover, because of a patchy distribution of H. 
pylori in the gastric mucosa, biopsy tissue examination 
may yield false negative results. Serological tests that 
detect anti-H. pylori IgG antibodies are non-invasive, 
less expensive, not influenced by sampling error, and 
less likely to be confounded by suppression of H 
pylori infection by colloidal bismuth, proton pump 
inhibitors, or antibiotics. The availability of such a 
diagnostic test that is non-invasive, cheap and rapid 
for detection of H.pylori in peptic ulcers is important 
since early institution of eradication therapy can help 
in curing this potentially disastrous condition. If 
serology is found to be as valid and accurate as 
histopathology in diagnosis of H.pylori, this can 
replace biopsy and histopathology since it is a rapid, 
cheap and non-invasive alternative.   
 
Patients and Methods 
     Total 191 patients both male and female between 20 
to 80 yrs of age (mean age was 41.72[SD=14.96] years) 
were included in the study. Among them 134 (70.2%) 
were males and 57 (29.8%) were females. Patients who 
were on, or had already received eradication therapy 
before laparotomy, those with any other additional 
cause of ulcer disease including gastric and duodenal 
carcinomas diagnosed mainly by history taking, 
clinical examination and computed tomography if 
suspected with CA and patients on chronic NSAID use 
for treatments of the various arthritis, chronic 
alcoholism and other major known causes of peptic 
ulcer disease were not included in the study. Patients 
presenting with an acute abdominal condition were 
assessed by their history and clinically by the presence 
of guarding, rigidity on their abdominal examination. 
They were subjected to relevant radiology to confirm 
the diagnosis of perforation with the presence of free 
gas under the diaphragm. During this work up, 
relevant base line investigations were sent after which 
management was started and they were put on 
nasogastric aspiration, parenteral fluids and antibiotics 
and were investigated for fitness for general anesthesia 
and surgery. Consent for surgery and inclusion in the 
study, were taken. Laparotomy was performed under 
general anesthesia and once perforated peptic ulcer 
was confirmed per-operatively, the blood sample was 
sent for H.pylori serology. Serum samples were tested 
with a commercially available enzyme linked 
immunosorbent assay (ELISA) kit for H.pylori IgG. 
     At the same time, gastric antral biopsies were taken 
for histopathology for H. pylori with Yeoman Biopsy 
Forceps, 15" (38.1 cm) shaft, 3.5 X 10 mm bite, with 
basket (MX Surgical, Integra Miltex) through the 
perforation site for Giemsa staining. At least 6-8 biopsy 
samples were obtained. Histological examination of 
tissue biopsy samples (was taken from four different 
parts of the Antrum) permitted detection of the 
bacterium together with evaluation of tissue damage 
reported by histopathology.  
 
Results 
     A total of 191 patients with diagnosed perforated 
peptic ulcer at laparotomy were included in the study 
which was conducted from April 2012 to Nov 2012 in 
Surgical Department, Pakistan Institute of Medical 
Sciences Islamabad. Among 191 patients, majority 
(70.2%) were males. The age ranged from 20 to 80 
years. The mean age was 41.72 years. Majority of  the 
perforations were found along first part of duodenum 
(Table 1) Eighty three (43.3%) patients presented 
within11 to 24 hours of perforation(Table 2) .H pylori 
serology was positive in 132 (69.1%) patients. The 
mean age of the patients with a positive serology was 
43.815.6 years whereas the mean age of the patients 
with a negative serology was 37.0512.1 years; this 
difference was statistically significant; p=0.004. One 
hundred and thirty (72.8%) patients had positive 
histopathology for H pylori, out of these 129 (92.8%) 
also had a positive H pylori serology and 10 (7.2%) 
had a negative serology. 52 (27.2%) patients had 
negative histopathology for H pylori. Out of these 3 
(5.8%) had a positive serology test and 49 (94.2%) had 
a negative serology. 129 were true positive i.e both had 
positive histopathology and serology and 52 were true 
negative i.e they had both a negative serology and a 
negative histopathology. The results were therefore 
correct in 181 (94.76%) cases. Hence the overall 
accuracy of serology in comparison to histopathology 
was 94.76%. The calculated sensitivity of serology in 
comparison to histopathology was 92.8%. The 
calculated specificity of serology in comparison to 
histopathology was 94.5%. The calculated positive 
predictive value (PPV) of serology in comparison to 
histopathology was 97.7%. The calculated negative 
predictive value (NPV) of serology in comparison to 
histopathology was 83.9%. 
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Table 1:Perforated peptic ulcer- Sites 
Site No(%) 
First part of 
duodenum 
146(76.4) 
Pre-pyloric region 27(14.1) 
Lesser curvature 18(9.4) 
 
Table 2: Perforated peptic ulcer- Time  
of presentation 






Table 3:H.pylori in perforated Ulcer- Summary 
of Histopathology and Serology results 






Positive 129 92.8 
Negative 10 7.2 




Positive 3 5.8 
Negative 49 94.2 
 Total 52 100.0 
 
Discussion 
      More than 95% of patients suffering from duodenal 
ulcers and about 70-80% of patients with gastric ulcers 
are H. pylori positive.11-13 ‘Test and treat’ strategy that 
involves non-invasive testing without endoscopy and 
eradication therapy in young patients is effective in 
management of dyspepsia. 12, 13 This calls for a simple, 
reliable and non-invasive diagnostic test for H.pylori 
infection in clinical practice. At present there is no 
single test for H.pylori that can be used as the ‘gold 
standard’.14 Culture, rapid urease test and histology 
require endoscopic biopsy of gastric mucosal tissue 
that is expensive, inconvenient for the patient and 
available only at specialized centers. Because of a 
patchy distribution of H. pylori in the gastric mucosa, 
biopsy tissue examination may yield false negative 
results.15 Serological tests that detect anti-H pylori IgG 
antibodies are non-invasive, less expensive, not 
influenced by sampling error, and less likely to be 
confounded by suppression of H. pylori infection by 
colloidal bismuth, proton pump inhibitors, or 
antibiotics.16  
    Serological tests though widely used, cannot 
differentiate a current infection from a past exposure.17 
 Performance of serological tests depends on the 
antigen preparation used, and as H pylori strains 
differ among geographic locations, local validation of 
the test is necessary. Pakistan is a developing country 
with a high prevalence of H pylori infection and peptic 
ulcer. Data regarding H. pylori infection in perforated 
peptic ulcers are conflicting.18-19 
    Since its discovery many tests have been designed 
for diagnosis of H. pylori. But no test is accurate 
enough to be the ‘gold standard’. Serological tests are 
widely used for non-invasive diagnosis but a positive 
serological test does not mean active infection.20 The 
commercial ELISA that we evaluated was very 
sensitive but less specific. Performance of the ELISA 
kit varies in different populations. Hung et al 
concluded that a quantitative ELISA test is suitable for 
the diagnosis of H. pylori infection in patients with 
atrophic gastritis because of its excellent sensitivity. In 
patients with atrophic gastritis, all invasive and 
noninvasive tests for the diagnosis of H. pylori 
infection have their restrictions because the bacterial 
load of H. pylori decreases gradually during the 
progression of gastric atrophy, and bacteria are 
unevenly distributed in the stomach. In cases with 
extensive intestinal metaplasia, H. pylori can 
disappear completely.21 If H. pylori infection is patchy 
or if the number of bacteria is low, invasive diagnostic 
tests based on gastric biopsies can yield inaccurate 
results because of sampling errors. 
    Serological testing is a useful noninvasive method 
for the diagnosis of Helicobacter pylori infection. It is 
easy for patients to accept the test because of its 
noninvasiveness, and the results can be quickly 
obtained. Furthermore, this assay is a global test that 
evaluates the entire stomach. Therefore, potential 
sampling errors can be avoided.22 The sensitivity of 
enzyme-linked immunosorbent assay (ELISA)-based 
serological tests ranges between 90% and 97%, and the 
specificity ranges between 50% and 96%.23-26 The 
sensitivity and specificity of serological tests mainly 
depend on the nature of the antigenic materials used. 
In addition to the antigens used, the presence of 
atrophic gastritis is also one of the important factors 
that influence the test’s accuracy. 
     A “gray zone” result is a significant limitation of 
serological tests. H. pylori infection induces mucosal 
inflammation in the stomach. Infected patients have 
shown a wide variety of systemic antibody responses, 
thereby leading to several indeterminate results in 
serological tests. In cases with indeterminate results, 
other tests should be performed to determine the 
status of H. pylori infection. In addition, the accuracy 
of serological tests might vary between different races 
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and geographic regions, possibly due to different 
antigenic properties of local bacterial strains and 
antibodies of commercial kits used for the diagnosis of 
H. pylori infection. The usefulness of a serological 
assay should be assessed in a local setting. In 
conclusion, the sensitivity of biopsy-based tests for the 
diagnosis of H. pylori infection decreases with the 
progression of atrophic gastritis. Quantitative ELISA is 
a noninvasive and sensitive test for detection of H. 
pylori infection in subjects with atrophic gastritis, but 
this test is less specific in the presence of atrophic 
gastritis. 
Conclusion 
1.Serological testing is a useful noninvasive method 
for the diagnosis of Helicobacter pylori infection. It is 
easy for patients to accept the test because of its 
noninvasiveness, and the results can be quickly 
obtained. This assay is a global test that evaluates the 
entire stomach. 
2. A combination of at least 2 tests (e.g. serology plus 
urea breath test) is necessary in clinical practice to 
diagnose H. pylori infection accurately in patients with 
atrophic gastritis or intestinal metaplasia. 
3. If discordant results of the tests exist, another 
sensitive test (e.g. histology) can be performed to 
determine the status of H. pylori 
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